![Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world](https://i0.wp.com/www.diabettech.com/wp-content/uploads/2018/03/is-hba1c-a-poor-yardstick-for-determining-access-to-new-t1d-treatments-in-the-real-world1.jpg?resize=326%2C245&ssl=1)
Is Hba1C a poor yardstick for determining access to new T1D treatments in the real world
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
If you’ve ever looked at a clinical trials document for a type 1 treatment, you’ll nearly always spot two things. Reduction in Hba1C is a […]
As many people (but let’s face it, not all) are aware, the NICE target for Hba1C level is 6.5% as this is the point at […]
If you have hung around in Diabetes circles on line for long enough, you will have heard about inhaled insulins. They have a speckled history […]
Following some discussions on the DCUK forum relating to DAFNE, I thought it would be an interesting topic to look into. Before I go on, […]
Copyright © 2024 | WordPress Theme by MH Themes